Ocular Therapeutix (Nasdaq: OCUL), a biopharmaceutical company focused on the development and commercialization of innovative therapies for diseases and conditions of the eye, today announced that Amar Sawhney, Ph.D., President and Chief Executive Officer, will provide an overview of the Company at the 21st Annual BioCentury Conference during a live presentation at 3:30pm ET on September 26, 2014. Dr. Sawhney and other members of the Company’s management team will also be available to participate in one-on-one meetings with investors who are registered to attend the conference.
Help employers find you! Check out all the jobs and post your resume.
